Wikiwand AI

QUCHMIC

Chemical compound From Wikipedia, the free encyclopedia

QUCHMIC (named using EMCDDA naming standards,[1] but regularly mis-named QUCHIC[nb 1]), also known as BB-22, SGT-32, or quinolin-8-yl 1-cyclohexylmethyl-1H-indole-3-8-carboxylate, is a designer drug offered by online vendors as a cannabimimetic agent, and was first detected being sold in synthetic cannabis products in Japan in early 2013,[2] and subsequently also in New Zealand.[3]

Other namesBB-22; SGT-32; quinolin-8-yl 1-cyclohexylmethyl-1H-indole-3-8-carboxylate
Legal status
Quick facts Clinical data, Other names ...
QUCHMIC
Clinical data
Other namesBB-22; SGT-32; quinolin-8-yl 1-cyclohexylmethyl-1H-indole-3-8-carboxylate
Legal status
Legal status
Identifiers
  • 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC25H24N2O2
Molar mass384.479 g·mol−1
3D model (JSmol)
  • C1CCC(CC1)CN2C=C(C3=CC=CC=C32)C(=O)OC4=CC=CC5=C4N=CC=C5
  • InChI=1S/C25H24N2O2/c28-25(29-23-14-6-10-19-11-7-15-26-24(19)23)21-17-27(16-18-8-2-1-3-9-18)22-13-5-4-12-20(21)22/h4-7,10-15,17-18H,1-3,8-9,16H2
  • Key:RHYGTJXOHOGQGI-UHFFFAOYSA-N
Close

The structure of QUCHMIC appears to use an understanding of structure-activity relationships within the indole class of cannabimimetics, although its design origins are unclear. QUCHMIC, along with QUPIC, QUFUBIC, 2F-QMPSB and NA-PINAC, represent a structurally unusual synthetic cannabinoid chemotype since they contain an ester linker at the indole 3-position rather than the precedented ketone of JWH-018 and its analogues, or the amide of SDB-001 and its analogues.

Pharmacology

QUCHMIC acts as a full agonist with a binding affinity of 0.217 nM at CB1 and 0.338 nM at CB2 cannabinoid receptors.[4]

See also

Notes

  1. The compound QUCHIC (quinolin-8-yl 1-cyclohexyl-1H-indole-3-8-carboxylate) has never been detected

References

Related Articles

Timelines

Top Qs

Fact Checks